Exagen Q1 revenue record $15.5M, but net loss widens to $3.8M

EXAGEN INC.

2025-Q1 EPS reported -$0.20 revenue$15,498,000

Revenue $15.5M (+7.5% YoY); net loss $(3.8)M vs $(3.4)M; adjusted EBITDA $(2.5)M vs $(2.0)M.
Trailing-12-month ASP rose to $419 from $377; AVISE CTD test volume grew.
FY2025 guidance: revenue at least $65M; targeting positive adjusted EBITDA in Q4 2025.
Closed $25M senior secured credit facility with Perceptive Advisors on April 25, 2025.
Combined cash and AR projected ~$28M as of April 30 after releasing held claims.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.